Rockville, MD, Sept. 04, 2024 (GLOBE NEWSWIRE) -- The global choroid plexus disorder treatment market is approximated at a value of US$ 130.2 million in 2024 and is forecasted to expand at a CAGR of 7.3% from 2024 to 2034, reveals Fact.MR, a market research and competitive intelligence provider, in its new study.
Choroid plexus disorders disrupt cerebrospinal fluid (CSF) production and flow leading to various neurological conditions such as hydrocephalus. Choroid plexus disorder treatment includes surgical interventions, medications, and supportive therapies such as radian therapy, immunotherapy, and chemotherapy that are aimed at managing symptoms and enhancing patient outcomes.
Innovations in brain imaging technologies such as positron emission tomography, magnetic resonance imaging, and computed tomography (CT) scans are set to improve early detection and monitoring rates of choroid plexus disorders.
Increasing focus on developing targeted therapies that specifically address underlying causes of choroid plexus disorders such as genetic mutations or inflammatory processes are expected to fuel overall market growth. Furthermore, advancements in minimally invasive surgical techniques, especially for cancer treatment, are expected to aid in mitigating recovery time and risk.
For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=10239
Key Takeaways from Market Study
- The global choroid plexus disorder treatment market is projected to reach US$ 262.3 million by 2034.
- The United States is estimated to hold 86.6% of the North American market share in 2024.
- The South Korea market is forecasted to reach a size of US$ 4.6 million by 2034.
- Demand for choroid plexus disorder treatment in India is forecasted to rise at a CAGR of 10.9% from 2024 to 2034.
- Carboplatin treatment is forecasted to account for 40.8% of the global market share by 2034.
“Personalized medications trend based on genetic profiling and biomarker analysis will aid in effective choroid plexus disorder treatment and drive overall market growth over the coming years,” says Fact.MR report.
Leading Players Driving Innovation in Choroid Plexus Disorder Treatment Market:
Celon Laboratories Ltd.; Cipla Ltd.; Gls Pharma Pvt. Ltd.; Zydus Cadila; Bristol-Myers Squibb; Fresenius Kabi; Pfizer; Sun Pharmaceuticals; Natco Pharma; Celltrion Healthcare; Genentech USA; Amgen Inc.
North America Holds Leading Market Position Driven by Presence of Advanced Healthcare Infrastructure:
North America is leading the global market for choroid plexus disorder treatment. Presence of advanced medical infrastructure, significant research and development investments, and high healthcare expenditure are key factors contributing to the production and demand for advanced choroid plexus disorder treatment solutions in the region.
Favorable reimbursement policies, robust healthcare systems, and presence of skilled medical professionals are all contributing to market growth in Europe. Rise in medical tourism in Europe is also generating lucrative opportunities for choroid plexus disorder medication producers.
Asia Pacific is considered to be a fast-growing market for choroid plexus disorder treatment solutions. Increasing awareness about neurological disorders and rising spending on healthcare infrastructure development are expected to offer high-growth opportunities for key market players.
Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=S&rep_id=10239
Choroid Plexus Disorder Treatment Market News:
- In patients with relapsing-remitting multiple sclerosis (RRMS), longitudinal growth of the choroid plexus is linked to the development of chronic lesions and neurodegeneration, per a study article published in February 2024 by Sage Journals.
- Researchers at Northwestern Medicine published the ground-breaking findings of the first human clinical trial in May 2023. The trial involved the deployment of a new skull-implantable ultrasonic device to treat brain tumours by opening the blood-brain barrier.
More Valuable Insights on Offer:
Fact.MR, in its new offering, presents an unbiased analysis of the global choroid plexus disorder treatment market, presenting historical demand data (2018 to 2023) and forecast statistics for the period (2024 to 2034).
The study divulges essential insights on the market based on indication (choroid plexus tumors, choroid plexus papillomas, low CSF (hydrocephalus)), treatment (ifosfamide, carboplatin, etoposide, bevacizumab, rapamycin, cyclophosphamide, others), age group (infants/pediatric, children, adults, geriatric), and distribution channel (retail pharmacies, hospital pharmacies, online pharmacies), across seven major regions of the world (North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, and MEA).
Check out More Related Studies Published by Fact.MR:
Psychotic Disorder Treatment Market: accounts for US$ 13.6 billion and is projected to surge past a valuation of US$ 24.5 billion by the end of 2032.
Peptide Based Hematological Disorders Therapeutics Market: will touch a value of nearly US$ 530 Mn in the year 2022 and grow at a robust CAGR during the assessment period.
Peptide Based Gastrointestinal Disorders Therapeutics Market: is set to reflect a double-digit CAGR between 2017 and 2022, to surpass a valuation of US$ 600 Mn.
Peptide-based Metabolic Disorders Therapeutics Market: is forecasted to increase at a stellar CAGR of 12% from 2023 to 2033. As a result, the global peptide-based metabolic disorder therapeutics market is projected to attain a valuation of US$ 77.9 billion by the end of 2033, up from its current size of US$ 25 billion.
Movement Disorder Market: is anticipated to register a CAGR of 11.1% during the years, 2017-2026.
About Us:
Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning.
With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures its clients receive actionable insights to capitalize on emerging opportunities and stay competitive.
Follow Us: LinkedIn | Twitter | Blog
